| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |